Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK Biobank
- 30 April 2024
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (7) , 2890-2904
Abstract
Aim: This study investigated the depot‐ and sex‐specific associations of adiposity indicators with incident multimorbidity and comorbidity pairs. Materials and Methods: We selected 382 678 adults without multimorbidity (≥2 chronic diseases) at baseline from the UK Biobank. General obesity, abdominal obesity and body fat percentage indices were measured. Results: Cox proportional hazard regression analyses of general obesity indices revealed that for every one‐unit increase in body mass index, the risk of incident multimorbidity increased by 5.2% (95% confidence interval 5.0%‐5.4%). A dose‐response relationship was observed between general obesity degrees and incident multimorbidity. The analysis of abdominal obesity indices showed that for every 0.1 increment in waist‐to‐height ratio and waist‐to‐hip ratio, the risk of incident multimorbidity increased by 42.0% (37.9%‐46.2%) and 27.9% (25.7%‐30.0%), respectively. Central obesity, as defined by waist circumference, contributed to a 23.2% increased risk of incident multimorbidity. Hip circumference and hip‐to‐height ratio had protective effects on multimorbidity onset. Consistent findings were observed for males and females. Body fat percentage elevated 3% (0.2%‐5.9%) and 5.3% (1.1%‐9.7%) risks of incident multimorbidity in all adults and females, respectively. Arm fat percentages elevated 5.3% (0.8%‐9.9%) and 19.4% (11.0%‐28.5%) risks of incident multimorbidity in all adults and males, respectively. The general obesity indices, waist circumference, waist‐to‐height ratio, waist‐to‐hip ratio and central obesity increased the onset of comorbidity pairs, whereas hip circumference and hip‐to‐height ratio decreased the onset of comorbidity pairs. These adiposity indicators mainly affect diabetes mellitus‐related comorbidity onset in males and hypertensive‐related comorbidity onset in females. Conclusions: Adiposity indicators are predictors of multimorbidity and comorbidity pairs and represent a promising approach for intervention.Keywords
Funding Information
- China Postdoctoral Science Foundation (2019M653669)
- National Natural Science Foundation of China (8191101420, 82103868)
- Natural Science Basic Research Program of Shaanxi Province (2020JQ‐094)
This publication has 28 references indexed in Scilit:
- Association of cognitive frailty and abdominal obesity with cardiometabolic multimorbidity among middle-aged and older adults: A longitudinal studyJournal of Affective Disorders, 2023
- Multilayered omics reveal sex- and depot-dependent adipose progenitor cell heterogeneityCell Metabolism, 2022
- Different Indicators of Adiposity and Fat Distribution and Cardiometabolic Risk Factors in Patients with Type 2 DiabetesObesity, 2021
- Associations of air pollution with obesity and body fat percentage, and modification by polygenic risk score for BMI in the UK BiobankEnvironmental Research, 2020
- Body size, body composition and endometrial cancer risk among postmenopausal women in UK BiobankInternational Journal of Cancer, 2020
- Association of obesity measures and multimorbidity in Pakistan: findings from the IMPACT studyPublic Health, 2020
- Relationship between body fat percentage and insulin resistance in adults with Bmi values below 25 Kg/M2 in a private clinicDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Evidence on multimorbidity from definition to intervention: An overview of systematic reviewsAgeing Research Reviews, 2017
- The sexual dimorphism of obesityMolecular and Cellular Endocrinology, 2015
- Body mass index and risk of mental disorders in the general population: Results from the Singapore Mental Health StudyJournal of Psychosomatic Research, 2013